The impact of Covid-19 in Africa is a ticking bomb on which the European Union (EDCTP) intervenes by supporting research projects. In response to this, a consortium of African and European universities and research institutes developed the ITAIL-COVID-19 project, aimed at implementation of novel and integrated laboratory testing approaches as a strategy against the spread of SARS-COV-2 in the Republic of Congo.
As part of the strengthening of health systems and in particular the regulation of drugs and health products within the Africlinique project, the headquarters of the World Health Organization (WHO),
An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including